Keyphrases
Antiviral Drugs
100%
Kaposi's Sarcoma-associated Herpesvirus
100%
Drug Sensitivity
100%
DNA Synthesis
45%
Ganciclovir
36%
Phosphonoformic Acid
36%
Cidofovir
27%
Kaposi Sarcoma
18%
Aciclovir
18%
Episomal
18%
Cell Culture
9%
High Dose
9%
Latency
9%
B-cell Lymphoma
9%
Phorbol Ester
9%
Lymphoma Cells
9%
Episome
9%
DNA Polymerase
9%
Phorbol 12-myristate 13-acetate
9%
Host DNA
9%
Virus DNA
9%
Causative Agents
9%
Prolonged Incubation
9%
Latent Form
9%
AIDS Patients
9%
Development Risk
9%
HHV-8
9%
DNA Virus
9%
Drug Assay
9%
Median Inhibitory Concentration
9%
Proviral DNA
9%
Medicine and Dentistry
In Vitro
100%
Human Herpesvirus 8
100%
Antiviral Susceptibility
100%
Antivirus Agent
41%
DNA Synthesis
41%
Foscarnet
33%
Ganciclovir
33%
Virus DNA
25%
Cidofovir
25%
Kaposi Sarcoma
16%
Aciclovir
16%
Low Drug Dose
8%
Drug Megadose
8%
Secretion (Process)
8%
B-Cell Lymphoma
8%
Lymphoma Cell
8%
Retrospective Study
8%
Incubation
8%
Episome
8%
Acetic Acid
8%
Phorbol
8%
Phorbol Ester
8%
DNA Polymerase
8%
Drug Determination
8%
BCBL-1 Cell Line
8%
Cell Culture
8%
IC50
8%
Pharmacology, Toxicology and Pharmaceutical Science
Antivirus Agent
100%
Human Herpesvirus 8
100%
Foscarnet
33%
Ganciclovir
33%
Cidofovir
25%
Aciclovir
16%
Virus DNA
16%
Kaposi Sarcoma
16%
Cell Culture
8%
Retrospective Study
8%
B Cell Lymphoma
8%
Phorbol
8%
Phorbol Ester
8%
IC50
8%
DNA Polymerase
8%